• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于骨转移性肿瘤细胞放射性核素治疗的放射性钯和钯联吡啶-双膦酸盐配合物。

The radioactive Pd and Pd palladium bipyridyl-bisphosphonate complexes for radionuclide therapy of bone metastatic tumor cells.

作者信息

Annamalaisamy Geeva Prasanth, Lyczko Monika, Bilewicz Aleksander

机构信息

Center of Radiochemistry and Nuclear Chemistry, Institute of Nuclear Chemistry and Technology Dorodna 16 Warsaw 03-195 Poland.

出版信息

RSC Adv. 2025 Jun 3;15(23):18501-18511. doi: 10.1039/d5ra02172c. eCollection 2025 May 29.

DOI:10.1039/d5ra02172c
PMID:40463346
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12132093/
Abstract

Two radioisotopes of palladium, Pd and Pd, are considered promising candidates for therapeutic applications because they emit Auger electrons, which are known for their effectiveness in targeting and destroying cancerous cells. We synthesized complexes of Pd and Pd with two bipyridyl and one alendronate molecule. The complexes demonstrated stability and a strong affinity for the surface of hydroxyapatite grains, the main mineral component of bones. Radioactive complexes show significantly higher cytotoxicity against human prostate (DU 145) and ovarian Her2 positive (SKOV-3) cancer cell lines compared to trastuzumab labeled with the Auger electron emitter I and cisplatin. The biological studies showed that both Pd, a pure Auger electron emitter, and Pd, which emits both beta and Auger electrons, demonstrate high cytotoxicity. Furthermore, it was observed that in the tested complexes, Ag, a decay product of Pd, was released from the complex following the decay of Pd. In contrast, Rh, a decay product of Pd, remained within the structure of the complex. The release of Rh from the Pd complex is inhibited by the presence of delocalized electrons in the aromatic bipyridyl ligand. The concept of using a Pd/Ag and Pd/Rh generator encourages further exploration of this treatment strategy.

摘要

钯的两种放射性同位素,钯-103和钯-109,被认为是治疗应用的有前景的候选物,因为它们发射俄歇电子,而俄歇电子以其在靶向和破坏癌细胞方面的有效性而闻名。我们合成了钯-103和钯-109与两个联吡啶和一个阿仑膦酸盐分子的配合物。这些配合物表现出稳定性以及对羟基磷灰石颗粒表面(骨骼的主要矿物质成分)的强亲和力。与用俄歇电子发射体碘-125标记的曲妥珠单抗和顺铂相比,放射性配合物对人前列腺(DU 145)和卵巢Her2阳性(SKOV-3)癌细胞系显示出显著更高的细胞毒性。生物学研究表明,作为纯俄歇电子发射体的钯-103和既发射β电子又发射俄歇电子的钯-109都表现出高细胞毒性。此外,观察到在测试的配合物中,钯-103的衰变产物银在钯-103衰变后从配合物中释放出来。相反,钯-109的衰变产物铑保留在配合物结构内。芳族联吡啶配体中离域电子的存在抑制了铑从钯-109配合物中的释放。使用钯-银和钯-铑发生器的概念鼓励进一步探索这种治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/08a4b98ab304/d5ra02172c-f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/981b0265971d/d5ra02172c-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/33da27265b15/d5ra02172c-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/a906b3704bd4/d5ra02172c-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/a5dc1cda5ce6/d5ra02172c-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/36c51720c373/d5ra02172c-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/bb0e0d02b6e0/d5ra02172c-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/a0035ba5f0ab/d5ra02172c-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/6e5f0c89cc32/d5ra02172c-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/1a66728a8a87/d5ra02172c-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/0539404cefcd/d5ra02172c-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/b8594a228138/d5ra02172c-f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/08a4b98ab304/d5ra02172c-f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/981b0265971d/d5ra02172c-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/33da27265b15/d5ra02172c-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/a906b3704bd4/d5ra02172c-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/a5dc1cda5ce6/d5ra02172c-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/36c51720c373/d5ra02172c-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/bb0e0d02b6e0/d5ra02172c-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/a0035ba5f0ab/d5ra02172c-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/6e5f0c89cc32/d5ra02172c-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/1a66728a8a87/d5ra02172c-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/0539404cefcd/d5ra02172c-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/b8594a228138/d5ra02172c-f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a98f/12132093/08a4b98ab304/d5ra02172c-f12.jpg

相似文献

1
The radioactive Pd and Pd palladium bipyridyl-bisphosphonate complexes for radionuclide therapy of bone metastatic tumor cells.用于骨转移性肿瘤细胞放射性核素治疗的放射性钯和钯联吡啶-双膦酸盐配合物。
RSC Adv. 2025 Jun 3;15(23):18501-18511. doi: 10.1039/d5ra02172c. eCollection 2025 May 29.
2
Au@Pd core-shell nanoparticle conjugated to trastuzumab for the therapy of HER2+ cancers: studies on the applicability of Pd/Ag in vivo generator in combined β auger electron therapy.与曲妥珠单抗偶联的金@钯核壳纳米颗粒用于HER2+癌症的治疗:关于钯/银体内发生器在联合β俄歇电子治疗中的适用性研究
EJNMMI Radiopharm Chem. 2023 Oct 11;8(1):26. doi: 10.1186/s41181-023-00212-4.
3
Pd/Ag in-vivo generator in the form of nanoparticles for combined β - Auger electron therapy of hepatocellular carcinoma.用于肝细胞癌联合β-俄歇电子治疗的纳米颗粒形式的钯/银体内发生器
EJNMMI Radiopharm Chem. 2024 Aug 13;9(1):59. doi: 10.1186/s41181-024-00293-9.
4
A solid support generator of the Auger electron emitter rhodium-103m from [Pd]palladium.一种由[钯]钯生成俄歇电子发射体铑-103m的固体载体发生器。
Appl Radiat Isot. 2020 Feb;156:108985. doi: 10.1016/j.apradiso.2019.108985. Epub 2019 Nov 14.
5
Palladium-103 (Pd/Rh), a promising Auger-electron emitter for targeted radionuclide therapy of disseminated tumor cells - absorbed doses in single cells and clusters, with comparison to Lu and Tb.钯-103(Pd/Rh),一种用于播散性肿瘤细胞靶向放射性核素治疗的有前景的俄歇电子发射体——单细胞和细胞簇中的吸收剂量,并与镥和铽作比较
Theranostics. 2024 Jul 8;14(11):4318-4330. doi: 10.7150/thno.95436. eCollection 2024.
6
Au@Pd Core-Shell Nanoparticles Conjugated to Panitumumab for the Combined β-Auger Electron Therapy of Triple-Negative Breast Cancer.与帕尼单抗偶联的金@钯核壳纳米颗粒用于三阴性乳腺癌的联合β-俄歇电子治疗
Int J Mol Sci. 2024 Dec 18;25(24):13555. doi: 10.3390/ijms252413555.
7
Recoil effect on beta-decaying in vivo generators, interpreted for (103)Pd/(103m)Rh.对体内β衰变发生器的反冲效应,针对(103)Pd/(103m)Rh进行解释。
Appl Radiat Isot. 2009 Jul-Aug;67(7-8):1401-4. doi: 10.1016/j.apradiso.2009.02.022. Epub 2009 Feb 20.
8
A possible in vivo generator 103Pd/103mRh--recoil considerations.一种可能的体内发生器103钯/103m铑——反冲考虑因素。
Appl Radiat Isot. 2008 Oct;66(10):1346-9. doi: 10.1016/j.apradiso.2008.02.088. Epub 2008 Mar 5.
9
Au@Pt Core-Shell Nanoparticle Bioconjugates for the Therapy of HER2+ Breast Cancer and Hepatocellular Carcinoma. Model Studies on the Applicability of Pt and Pt Radionuclides in Auger Electron Therapy.Au@Pt 核壳纳米粒子生物缀合物用于 HER2+乳腺癌和肝细胞癌的治疗。Pt 和 Pt 放射性核素在俄歇电子治疗中适用性的模型研究。
Molecules. 2021 Apr 3;26(7):2051. doi: 10.3390/molecules26072051.
10
Induction of DNA-double-strand breaks by auger electrons from 99mTc complexes with DNA-binding ligands.具有DNA结合配体的99mTc配合物产生的俄歇电子诱导DNA双链断裂。
Chembiochem. 2005 Feb;6(2):414-21. doi: 10.1002/cbic.200400210.

本文引用的文献

1
Pd/Ag in-vivo generator in the form of nanoparticles for combined β - Auger electron therapy of hepatocellular carcinoma.用于肝细胞癌联合β-俄歇电子治疗的纳米颗粒形式的钯/银体内发生器
EJNMMI Radiopharm Chem. 2024 Aug 13;9(1):59. doi: 10.1186/s41181-024-00293-9.
2
Palladium-103 (Pd/Rh), a promising Auger-electron emitter for targeted radionuclide therapy of disseminated tumor cells - absorbed doses in single cells and clusters, with comparison to Lu and Tb.钯-103(Pd/Rh),一种用于播散性肿瘤细胞靶向放射性核素治疗的有前景的俄歇电子发射体——单细胞和细胞簇中的吸收剂量,并与镥和铽作比较
Theranostics. 2024 Jul 8;14(11):4318-4330. doi: 10.7150/thno.95436. eCollection 2024.
3
Marshalling the Potential of Auger Electron Radiopharmaceutical Therapy.
调集正电子放射性药物治疗的潜力。
J Nucl Med. 2023 Sep;64(9):1344-1351. doi: 10.2967/jnumed.122.265039. Epub 2023 Aug 17.
4
Recent Trends in the Development of Novel Metal-Based Antineoplastic Drugs.新型金属抗肿瘤药物的研究进展。
Molecules. 2023 Feb 18;28(4):1959. doi: 10.3390/molecules28041959.
5
Core-shell structured gold nanoparticles as carrier for Dy/Ho in vivo generator.核壳结构金纳米颗粒作为镝/钬体内发生器的载体。
EJNMMI Radiopharm Chem. 2022 Jul 19;7(1):16. doi: 10.1186/s41181-022-00170-3.
6
Bone tumor-targeted delivery of theranostic Pt-bisphosphonate complexes promotes killing of metastatic tumor cells.骨肿瘤靶向递送诊疗一体化铂-双膦酸盐复合物可促进转移性肿瘤细胞的杀伤。
Mater Today Bio. 2020 Dec 7;9:100088. doi: 10.1016/j.mtbio.2020.100088. eCollection 2021 Jan.
7
Potent candidates for Targeted Auger Therapy: Production and radiochemical considerations.潜在的靶向 Auger 治疗候选物:生产和放射化学方面的考虑。
Nucl Med Biol. 2021 Mar-Apr;94-95:1-19. doi: 10.1016/j.nucmedbio.2020.12.001. Epub 2020 Dec 13.
8
Targeting of radioactive platinum-bisphosphonate anticancer drugs to bone of high metabolic activity.放射性铂双膦酸盐抗癌药物对高代谢活性骨的靶向作用。
Sci Rep. 2020 Apr 3;10(1):5889. doi: 10.1038/s41598-020-62039-2.
9
Multi-target heteroleptic palladium bisphosphonate complexes.多靶点杂配钯双膦酸盐配合物。
J Biol Inorg Chem. 2020 May;25(3):509-519. doi: 10.1007/s00775-020-01779-y. Epub 2020 Mar 30.
10
A solid support generator of the Auger electron emitter rhodium-103m from [Pd]palladium.一种由[钯]钯生成俄歇电子发射体铑-103m的固体载体发生器。
Appl Radiat Isot. 2020 Feb;156:108985. doi: 10.1016/j.apradiso.2019.108985. Epub 2019 Nov 14.